MORC2 was significantly over-expressed in 26 of the 33 tumor types (Figure 1A), and the expression of MORC2 in CRC tumors was significantly higher than that in peri-cancerous tissues in the paired experimental group (p < 0.001, Figure 1B) and the unpaired experimental group (p < 0.001, Figure 1C). The gene discussed is MORC2; the disease is colorectal carcinoma.